After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol Myers Squibb is conducting another round of job cuts in the Garden State.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback